Trial Profile
Safety and efficacy of meloxicam oral suspension in JRA [juvenile rheumatoid arthritis] (subtrial of 107.208).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2009
Price :
$35
*
At a glance
- Drugs Meloxicam (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 28 Mar 2007 New trial record.